EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Anti-Müllerian hormone a surrogate of follicular fluid oxidative stress in polycystic ovary syndrome?

Emídio Vale-Fernandes, Mafalda V Moreira, Bárbara Rodrigues, Sofia S Pereira, Carla Leal, Márcia Barreiro, António Tomé, Mariana P Monteiro

Frontiers in Cell and Developmental Biology · 01.07.2024 · 12

DOI: 10.3389/fcell.2024.1408879 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Cell and Developmental Biology, online erschienen am 01.07.2024. Verfasst von Emídio Vale-Fernandes und 7 weiteren Autor:innen. Beteiligte Einrichtung: Centre for Medically Assisted Procreation/Public Gamete Bank, Gynaecology Department, Centro Materno-Infantil do Norte Dr. Albino Aroso (CMIN), Unida…. Die Arbeit wurde bisher 32-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Polycystic ovary syndrome (PCOS) is the most common endocrinopathy in women at childbearing age. Anti-Müllerian hormone (AMH) is a widely accepted sensitive marker of ovarian reserve, which has been suggested that could also act as biomarker of ovarian morphology for PCOS diagnosis. Oxidative stress (OS) is known to be associated and have a negative impact factor in several reproductive conditions, including PCOS. However, the relationship between circulating AMH and OS within the follicular fluid (FF), and its potential impact on in vitro fertilization (IVF) outcomes of women with PCOS, remains largely unexplored. A total of 84 women, with PCOS (n = 30) or ovulatory controls (n = 54), were enrolled in this study. Women underwent individualized controlled ovarian stimulation for oocyte retrieval. Blood and FF obtained from mature follicles were collected at the time of oocyte retrieval, for measuring total testosterone, ∆4-androstenedione, progesterone, sex hormone binding globulin (SHBG) and AMH. OS in the FF was assessed by measuring total antioxidant capacity (TAC) through the ferric reducing antioxidant power (FRAP) and lipid peroxidation (LPO) by quantification of malondialdehyde (MDA) levels. Our results demonstrated that women with PCOS had significantly higher plasma levels of AMH, ∆4-androstenedione, total testosterone and a free androgen index (FAI) than observed in non-PCOS controls. In women with PCOS, total testosterone and AMH levels in the FF were also higher, while TAC was lower compared to non-PCOS. Furthermore, circulating AMH levels were positively correlated with ∆4-androstenedione, albeit negatively correlated with TAC. In this study we demonstrated that the susceptibility to OS, as assessed by the total antioxidant capacity in the FF, is higher in women with PCOS and inversely related to AMH levels. This study results lead us to forge the reasonable hypothesis that the greater susceptibility to OS within the follicle microenvironment is potentially at the end of a roadway that starts with elevated ∆4-androstenedione and AMH within the FF, which in turn are mirrored by circulating AMH and androgen levels. Thus, suggesting that circulating AMH levels could act as a surrogate biomarker of follicular fluid oxidative stress in women with PCOS.

Schlagwörter

Stichwörter der Autor:innen

Anti-Müllerian hormonefollicular fluidin vitro fertilizationoxidative stresspolycystic ovary syndrome

Autor:innen und Institutionen

  • Centre for Medically Assisted Procreation/Public Gamete Bank, Gynaecology Department, Centro Materno-Infantil do Norte Dr. Albino Aroso (CMIN), Unidade Local de Saúde de Santo António (ULSSA), Porto, Portugal.
  • UMIB - Unit for Multidisciplinary Research in Biomedicine, ICBAS - School of Medicine and Biomedical Sciences, University of Porto, Porto, Portugal.
  • ITR - Laboratory for Integrative and Translational Research in Population Health, Porto, Portugal.
  • Gynaecology Department, Centro Materno-Infantil do Norte Dr. Albino Aroso (CMIN), Unidade Local de Saúde de Santo António (ULSSA), Porto, Portugal.
  • i3S - Instituto de Investigação e Inovação em Saúde, Universidade do Porto, Porto, Portugal.
  • Molecular Genetics Unit, Centro de Genética Médica Dr. Jacinto Magalhães (CGM), Unidade Local de Saúde de Santo António (ULSSA), Porto, Portugal.

Zitieren

APA

Vale-Fernandes, E., Moreira, M. V., Rodrigues, B., Pereira, S. S., Leal, C., Barreiro, M., Tomé, A., & Monteiro, M. P. (2024). Anti-Müllerian hormone a surrogate of follicular fluid oxidative stress in polycystic ovary syndrome?. Frontiers in Cell and Developmental Biology, 12. https://doi.org/10.3389/fcell.2024.1408879

Vancouver

Vale-Fernandes E, Moreira MV, Rodrigues B, Pereira SS, Leal C, Barreiro M, et al. Anti-Müllerian hormone a surrogate of follicular fluid oxidative stress in polycystic ovary syndrome?. Frontiers in Cell and Developmental Biology. 2024;12. doi:10.3389/fcell.2024.1408879

BibTeX
@article{ValeFernandes2024,
  author = {Vale-Fernandes, Emídio and Moreira, Mafalda V and Rodrigues, Bárbara and Pereira, Sofia S and Leal, Carla and Barreiro, Márcia and Tomé, António and Monteiro, Mariana P},
  title = {Anti-Müllerian hormone a surrogate of follicular fluid oxidative stress in polycystic ovary syndrome?},
  journal = {Frontiers in Cell and Developmental Biology},
  year = {2024},
  volume = {12},
  doi = {10.3389/fcell.2024.1408879}
}
Kostenlos starten →